Sign in

CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Mineralys Therapeutics, Inc.

Sign in to watch
Ticker
MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
841966887
Phone
(888) 378-6240
Business address
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,403,032
in 5 filings, $2.4M under 10b5-1 plans

Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Slingsby Brian Taylor −$3.0M Director sold 1% of stake
  2. Congleton Jon −$1.9M Chief Executive Officer sold 12% of stake
  3. Warren Eric −$402K Chief Commercial Officer sold 28% of stake
  4. Karydas Daphne −$86K Director sold 33% of stake

Reading 62 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-22 Slingsby Brian Taylor Director Other acquisition · Stock Option +22,000 22,000

Page 17 of 17 · 321 trades